VLP Therapeutics Wins the 2015 Life Sciences Impact Grant Award from the Montgomery County Department of Economic Development

GAITHERSBURG, Md., March 2, 2015 /PRNewswire/ -- VLP Therapeutics, LLC. ("VLP"), a Gaithersburg-based biotechnology company focusing on the research and development of therapeutic and preventative vaccines and next generation antibody agents based upon a novel and proprietary vaccine technology, today announced that it received a 2015 Life Sciences Impact Grant Award from the Montgomery County Department of Economic Development (MCDED).  The grant, created by MCDED, is awarded to life sciences companies in Montgomery County to support the furthering of business and product development goals.

"We are very honored to be selected as one of the recipients of a Life Science Impact Grant Awards," said Dr. Wataru Akahata, Ph.D., Co-Founder and Chief Executive Officer of VLP. "We will apply the IMPACT grant funding toward advancing our malaria vaccine candidate into clinical trials. Malaria is one of the most serious public health problems worldwide and a leading cause of death in many developing countries. However, there is currently no vaccine available. The grant will not only facilitate our product development plan for this program and but also further our commitment to developing novel and innovative vaccines for diseases that currently lack treatments and contributing to the improvement of global public health," Dr. Akahata continued.    

About VLP Therapeutics
VLP was established in 2012 by a group of seasoned entrepreneurs based upon a novel, proprietary vaccine technology discovered by its co-founder Dr. Akahata.  Its vision is to combat the 21^st century global public health problems through revolutionary i-alphaVLP Technology, and the mission is to develop innovative medical treatment which transforms traditional vaccine and targeted antibody therapies to address global unmet medical needs. VLP is currently developing preventative and therapeutic vaccines as well as next generation of targeted antibody agents to treat cancer, infectious diseases, auto-immune diseases and neurological diseases. 

About the Montgomery County Department of Economic Development
MCDED is charged with implementing the County's economic development vision of being a globally-competitive, highly-diversified and knowledge-based economy that provides for the retention and growth of existing companies, stimulates new job creation and enhances entrepreneurial opportunities for all businesses. The Department offers a broad range of programs, services, partnering opportunities and strategic financing resources to stimulate and expand the County's business, job and tax base. More information can be found at our website www.choosemontgomerymd.com.

For more information, please visit www.vlptherapeutics.com.

SOURCE VLP Therapeutics, Inc.

Related Links

http://www.vlptherapeutics.com